PXD056410
PXD056410 is an original dataset announced via ProteomeXchange.
Dataset Summary
Title | Longitudinal analysis of B- and T-cell responses to SARS-CoV-2 recombinant S-protein vaccine S-268019-b in phase 1/2 priming and booster study |
Description | The durability of vaccine-induced immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is crucial for preventing infection, especially severe disease. This follow-up report after homologous booster vaccination in a phase 1/2 study of S-268019-b (a recombinant spike protein vaccine) confirms the long-term safety, tolerability, and immunogenicity. Booster vaccination of S-268019-b resulted in an enhancement of serum neutralizing antibody (NAb) titers and a broad range of viral neutralization. Single-cell immune profiling revealed persistent and mature antigen-specific memory B cells and T follicular helper cells, with increased B-cell receptor diversity. The expansion of B- and T-cell repertoires and cross-reactive NAbs targeting conserved epitopes within the receptor-binding domain following a booster, accounted for the broad-spectrum neutralizing activity. These finding highlights the potential of S-268019-b to provide broad and robust protection against a range of SARS-CoV-2 variants, addressing a critical challenge in the ongoing fight against coronavirus disease 2019 (COVID-19). |
HostingRepository | jPOST |
AnnounceDate | 2025-03-05 |
AnnouncementXML | Submission_2025-03-04_22:10:07.549.xml |
DigitalObjectIdentifier | |
ReviewLevel | Non peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Masahiro Takayama |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | unknown modification; unknown modification |
Instrument | instrument |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
---|---|---|---|
0 | 2024-09-30 19:34:00 | ID requested | |
⏵ 1 | 2025-03-04 22:10:07 | announced |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: SARS-CoV-2, S268019b, COVID-19 vaccine, Immunogenicity, Neutralizing antibodies, Single-cell analysis, Repertoire analysis, Humoral immunity, Cellular immunity, Vaccine safety |
Contact List
Shinya Omoto | |
---|---|
lab head | |
Masahiro Takayama | |
contact affiliation | Shionogi & Co., Ltd. |
dataset submitter |
Full Dataset Link List
jPOST dataset URI |
Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.jpostdb.org/JPST003388/ |